Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Idiopathic recurrent angioedema.

Evangelo Frigas¹, Miguel Park

¹Division of Allergic Disease and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. frigas.evangelo@mayo.edu

Immunology and Allergy Clinics of North America

|November 7, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pediatric asthma management via integration of a remote spirometry device into an EHR-based artificial intelligence-powered clinical decision support system: A feasibility pragmatic clinical trial.

Contemporary clinical trials·2025

Same author

Incidence and mortality indicate sex differences in chronic rhinosinusitis with nasal polyposis.

The journal of allergy and clinical immunology. In practice·2025

Same author

Association of delayed asthma diagnosis with asthma exacerbations in children.

The journal of allergy and clinical immunology. Global·2025

Same author

Reply to "Higher may not be better".

The journal of allergy and clinical immunology. In practice·2025

Same author

The Immediate and Delayed Maximal Nonirritating Skin Testing Concentrations of β-Lactam Antibiotics.

The journal of allergy and clinical immunology. In practice·2024

Same author

Reply.

The Journal of allergy and clinical immunology·2023

Same journal

Anaphylaxis: State-of-the-Art.

Immunology and allergy clinics of North America·2026

Same journal

Upending Impending Doom.

Immunology and allergy clinics of North America·2026

Same journal

Mast Cell Activation Syndrome and Mimickers.

Immunology and allergy clinics of North America·2026

Same journal

Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis.

Immunology and allergy clinics of North America·2026

Same journal

Emerging Therapies for Anaphylaxis.

Immunology and allergy clinics of North America·2026

Same journal

Novel Epinephrine Delivery Devices.

Immunology and allergy clinics of North America·2026

See all related articles

Treating chronic idiopathic angioedema, with or without urticaria, is challenging due to limited treatment effectiveness and high costs. Promising new medications are currently in clinical trials for these conditions.

Area of Science:

Immunology
Dermatology
Allergy

Background:

Idiopathic, chronic, and recurrent angioedema, often accompanied by urticaria, presents significant therapeutic challenges.
Current treatment strategies frequently offer only partial relief and are associated with substantial patient and healthcare burdens.

Purpose of the Study:

To review the difficulties in managing chronic idiopathic angioedema with or without urticaria.
To highlight the potential of novel pharmacological agents currently under clinical investigation.

Main Methods:

Literature review of existing treatment modalities for chronic angioedema and urticaria.
Analysis of emerging therapeutic options in clinical development.

Main Results:

Related Experiment Videos

Established treatments for chronic angioedema and urticaria demonstrate limited efficacy and are resource-intensive.
Emerging medications show potential for improved effectiveness in managing these conditions.

Conclusions:

The management of chronic idiopathic angioedema and urticaria remains a complex clinical problem.
New investigational drugs offer hope for more effective and manageable treatment options in the future.